Avricore Health Inc.
AVCR.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 23.27% | 87.21% | 79.26% | 38.26% | 62.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.27% | 87.21% | 79.26% | 38.26% | 62.06% |
| Cost of Revenue | 8.11% | 107.89% | 53.25% | 5.26% | 88.83% |
| Gross Profit | 63.32% | 58.67% | 130.81% | 196.30% | 17.95% |
| SG&A Expenses | 9.44% | -37.70% | -15.22% | -5.00% | 93.25% |
| Depreciation & Amortization | 0.00% | -16.67% | 150.00% | 100.52% | -99.13% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.68% | 20.99% | 21.57% | 10.89% | 70.25% |
| Operating Income | 43.06% | 128.77% | 218.23% | 144.56% | -107.24% |
| Income Before Tax | 38.21% | 118.67% | 188.28% | 124.29% | -53.65% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 38.21% | 118.67% | 188.28% | 124.29% | -53.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.21% | 118.67% | 188.28% | 124.29% | -53.65% |
| EBIT | 43.06% | 128.77% | 218.23% | 144.56% | -107.24% |
| EBITDA | 71.70% | 215.06% | 491.31% | 303.36% | -184.32% |
| EPS Basic | 38.10% | 119.05% | 192.86% | 122.22% | -50.00% |
| Normalized Basic EPS | 38.46% | 115.38% | 177.78% | 127.27% | -44.44% |
| EPS Diluted | 38.10% | 119.05% | 192.86% | 122.22% | -50.00% |
| Normalized Diluted EPS | 38.46% | 115.38% | 177.78% | 127.27% | -44.44% |
| Average Basic Shares Outstanding | 0.76% | 0.24% | 0.45% | 1.30% | 1.99% |
| Average Diluted Shares Outstanding | 0.76% | 6.00% | 0.45% | 1.30% | 1.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |